Fed. Circ. Probes Predictability Of Hair Loss Treatment Patent
A Federal Circuit panel seemed skeptical Monday of Sun Pharmaceutical Industries Inc.'s appeal of a Patent Trial and Appeal Board's ruling that invalidated as obvious a patent related to a potential...To view the full article, register now.
Already a subscriber? Click here to view full article